435 related articles for article (PubMed ID: 18755494)
21. A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
Trinei M; Lanfrancone L; Campo E; Pulford K; Mason DY; Pelicci PG; Falini B
Cancer Res; 2000 Feb; 60(4):793-8. PubMed ID: 10706082
[TBL] [Abstract][Full Text] [Related]
22. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma.
Dalton RR; Rassidakis GZ; Atwell C; Wang S; Oyarzo MP; Medeiros LJ
Hum Pathol; 2005 Jul; 36(7):806-11. PubMed ID: 16084951
[TBL] [Abstract][Full Text] [Related]
25. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
Balachandran I; Walker JW; Broman J
Diagn Cytopathol; 2010 Mar; 38(3):213-6. PubMed ID: 19774614
[TBL] [Abstract][Full Text] [Related]
26. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
27. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
Morley AM; Verity DH; Meligonis G; Rose GE
Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
[TBL] [Abstract][Full Text] [Related]
28. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
29. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome.
Zanelli M; Valli R; Capodanno I; Ragazzi M; Ascani S
Int J Surg Pathol; 2015 Feb; 23(1):78-83. PubMed ID: 24868005
[TBL] [Abstract][Full Text] [Related]
31. [Cytomorphology and molecular characterization of CLTC-ALK rearrangement in 2 cases of ALK-positive diffuse large B-cell lymphoma with extensive bone marrow involvement].
Choung HS; Kim HJ; Kim WS; Kim K; Kim SH
Korean J Lab Med; 2008 Apr; 28(2):89-94. PubMed ID: 18458503
[TBL] [Abstract][Full Text] [Related]
32. ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas.
Gesk S; Gascoyne RD; Schnitzer B; Bakshi N; Janssen D; Klapper W; Martín-Subero JI; Parwaresch R; Siebert R
Leukemia; 2005 Oct; 19(10):1839-40. PubMed ID: 16107887
[No Abstract] [Full Text] [Related]
33. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
34. A study on nm23-H1 expression in diffuse large B-cell lymphoma that was treated with CyclOBEAP plus rituximab therapy.
Niitsu N; Tamaru J; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Okamoto M
Ann Hematol; 2011 Feb; 90(2):185-92. PubMed ID: 20809421
[TBL] [Abstract][Full Text] [Related]
35. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma.
Liang X; Meech SJ; Odom LF; Bitter MA; Ryder JW; Hunger SP; Lovell MA; Meltesen L; Wei Q; Williams SA; Hutchinson RN; McGavran L
Am J Clin Pathol; 2004 Apr; 121(4):496-506. PubMed ID: 15080301
[TBL] [Abstract][Full Text] [Related]
36. Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin.
Bonvini P; Gastaldi T; Falini B; Rosolen A
Cancer Res; 2002 Mar; 62(5):1559-66. PubMed ID: 11888936
[TBL] [Abstract][Full Text] [Related]
37. Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma.
Koivula S; Valo E; Raunio A; Hautaniemi S; Leppä S
Oncol Rep; 2011 Apr; 25(4):1183-90. PubMed ID: 21318224
[TBL] [Abstract][Full Text] [Related]
38. Composite T lymphoblastic leukemia/lymphoma and diffuse large B-cell lymphoma: case report.
Niino D; Ohsaki K; Arakawa F; Watanabe J; Kimura Y; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Sugita Y; Ohshima K; Okamura T
Pathol Int; 2011 Jun; 61(6):363-8. PubMed ID: 21615612
[TBL] [Abstract][Full Text] [Related]
39. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M
Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393
[TBL] [Abstract][Full Text] [Related]
40. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements.
Shi M; Miron PM; Hutchinson L; Woda BA; Nath R; Cerny J; Yu H
Hum Pathol; 2011 Oct; 42(10):1562-7. PubMed ID: 21497367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
